TTK Healthcare Ltd.
Snapshot View

View in App

Prices View details >>

966.30 -17.95 ▼-1.8%

30 January 2023, 04:01:00 PM
Volume: 1,026

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.ttkhealthcare.com
Market Cap 1,360.89 Cr.
Enterprise Value(EV) 643.24 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 20.27 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 47.51 Trailing Twelve Months Ending 2022-09
Industry PE 32.78 Trailing Twelve Months Ending 2022-09
Book Value / Share 653.86 Trailing Twelve Months Ending 2022-09
Price to Book Value 1.47 Calculated using Price: 963.10
Dividend Yield 1.04 Period Ending 2022-03
No. of Shares Subscribed 1.41 Cr. 14,130,333 Shares
FaceValue 10
Company Profile
T T K Healthcare Ltd was incorporated in 1958 and went public in the same year. The company's brand wagon consists of products that are sought after by a wide range of customers. The Woodward's Gripe Water brand is the market leader in the baby care category. The Eva range of personal care products (Talc, Deodorant, Skincare) bring together the gentle touch of nature, backed by TTK's extensive research.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-1.82%
1 Week
-3.94%
1 Month
-3.72%
3 Month
+4.27%
6 Month
+13.86%
1 Year
+42.45%
2 Year
+72.51%
5 Year
+12.37%
10 Year
+86.44%

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 12.64 14.94 18.46 13.16 9.52 10.25 5.01 13.76 6.02
Return on Capital Employed (%) 18.12 20.71 23.85 18.63 15.42 15.46 8.28 8.38 8.59
Return on Assets (%) 5.51 6.27 7.85 6.38 5.28 5.99 2.94 8.04 3.56

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 107 118 136 157 233 251 249 295 330 928
Non Curr. Liab. 27 28 16 8 2 2 7 4 1 3
Curr. Liab. 106 129 150 120 168 157 172 189 221 300
Minority Int.
Equity & Liab. 240 275 303 285 403 411 427 488 551 1,231
Non Curr. Assets 77 109 119 118 147 139 129 113 102 97
Curr. Assets 163 166 184 167 256 272 298 375 449 1,133
Misc. Exp. not W/O
Total Assets 240 275 303 285 403 411 427 488 551 1,231

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 416 483 519 528 578 628 646 476 599 734
Other Income 6 7 6 6 8 8 9 10 16 31
Total Income 422 489 524 534 585 636 655 486 616 764
Total Expenditure -396 -453 -478 -489 -535 -578 -617 -457 -577 -704
PBIDT 26 36 46 44 50 57 37 29 38 60
Interest -3 -4 -3 -3 -5 -3 -3 -2 -3 -6
Depreciation -3 -6 -7 -12 -15 -15 -14 -13 -13 -13
Taxation -7 -10 -13 -10 -12 -15 -7 14 -6 -13
Exceptional Items 8 2
PAT 12 16 23 19 18 24 12 37 19 29
Adjusted EPS 16 21 29 24 13 17 9 26 13 20

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 24 13 39 37 18 25 17 20 96 45
Cash Fr. Inv. -1 -15 -49 -27 5 -23 10 -13 -77 -31
Cash Fr. Finan. -2 2 3 -11 -23 -7 -31 -10 -17 -9
Net Change 22 0 -7 0 0 -4 -4 -4 2 5
Cash & Cash Eqvt 83 84 77 77 19 15 11 8 10 15

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 74.56 74.56 74.56 74.56 74.56 74.56 74.56 74.56 74.56
Public 25.44 25.44 25.44 25.44 25.44 25.44 25.44 25.44 25.44
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 06 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
In compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 we are forwarding herewith a copy of the Certificate dated 5th January 2023 received from M/s Data Software Research Co. Pvt. Ltd. Chennai 600 006 the Registrar and Share Transfer Agent of the Company for the Quarter ended 31st December 2022.
Fri, 06 Jan 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Loss / Misplacement of Share Certificates and Receipt of Application for issuance of Duplicate Share Certificates.
Fri, 06 Jan 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Loss / Misplacement of Share Certificates and Receipt of Application for issuance of Duplicate Share Certificates.

Technical Scans View Details >>

Mon, 30 Jan 2023
Making Lower Lows for 3 days Making Lower Lows for 3 days
Close Within 52 Week High Zone Close Within 52 Week High Zone
High Increase in 1 Year High Increase in 1 Year
High Increase in 2 Years High Increase in 2 Years
Close Crossing 50 SMA From Above Close Crossing 50 SMA From Above

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 252,338.06 1,051.70 +0.8%
Divi's Laboratories Ltd. 89,367.34 3,366.40 -0.6%
Cipla Ltd. 83,741.18 1,037.50 -0.9%
Dr. Reddy's Laboratories Ltd. 72,084.75 4,328.80 +0.3%
Apollo Hospitals Enterprise Ltd. 61,094.10 4,249.00 +0.1%
Torrent Pharmaceuticals Ltd. 52,291.51 1,545.05 +0.5%
Abbott India Ltd. 44,555.01 20,967.75 -1.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 61.43 1,051.70 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-09 29.89 3,366.40 -0.6%
Cipla Ltd. Consolidated 2022-12 31.74 1,037.50 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 19.79 4,328.80 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 72.76 4,249.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.93 1,545.05 +0.5%
Abbott India Ltd. Standalone 2022-09 50.53 20,967.75 -1.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.75 1,051.70 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-09 7.37 3,366.40 -0.6%
Cipla Ltd. Consolidated 2022-12 3.69 1,037.50 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.28 4,328.80 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.21 4,249.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.20 1,545.05 +0.5%
Abbott India Ltd. Standalone 2022-09 16.41 20,967.75 -1.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,051.70 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,366.40 -0.6%
Cipla Ltd. Consolidated 2022-03 0.04 1,037.50 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,328.80 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,249.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,545.05 +0.5%
Abbott India Ltd. Standalone 2022-03 0.00 20,967.75 -1.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,051.70 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,366.40 -0.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,037.50 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,328.80 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,249.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,545.05 +0.5%
Abbott India Ltd. Standalone 2022-03 29.95 20,967.75 -1.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,051.70 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,366.40 -0.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,037.50 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,328.80 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,249.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,545.05 +0.5%
Abbott India Ltd. Standalone 2022-03 29.95 20,967.75 -1.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,051.70 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,366.40 -0.6%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,037.50 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,328.80 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,249.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,545.05 +0.5%
Abbott India Ltd. Standalone 2022-03 4,919.27 20,967.75 -1.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,051.70 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,366.40 -0.6%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,037.50 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,328.80 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,249.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,545.05 +0.5%
Abbott India Ltd. Standalone 2022-03 798.70 20,967.75 -1.2%

FAQ's On TTK Healthcare Ltd.

What is TTK Healthcare share price?
Can I buy TTK Healthcare shares now?
What is the Dividend Yield of TTK Healthcare?
What is the Market Cap of TTK Healthcare?
What are the key metrics to analyse TTK Healthcare?
What is the 52 Week High and Low of TTK Healthcare?
What is the trend of TTK Healthcare share price?